• MDB Direct
  • Community Portal
  • Submit Your Big Idea
MDB Capital
  • Why Public Venture?
    • What is Public Venture?
    • Public Venture Advantage
    • How to Invest
    • MDB Outcomes
  • Why MDB?
    • MDB Difference
    • Investment Criteria
    • Curation Process
    • Outcomes
    • Launch Capabilities
    • MDB Capital Brokerage
    • Community
      • Membership Group
      • Member Criteria & Benefits
  • MDB Direct
    • Overview
    • MDB Direct
    • IRAs
    • Open an Account
  • Media
    • Videos
    • Press Releases
    • Articles
    • Reports
  • About
    • Overview
    • Our Platform
    • Value Creation
    • Join Us
    • Contact
    • Leadership Team
    • Submit Big Idea
    • Subsidiaries
  • MDBH Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Stock Info
    • Governance
    • Email Alerts
    • IR Contact
    • Events
Select Page
Resurgence of Biotech Stocks

Resurgence of Biotech Stocks

by Staff | Feb 27, 2023

Dealmaking in Biotech Showing Life

Dealmaking in Biotech Showing Life

by Staff | Feb 27, 2023

Next Entries »

Recent Posts

  • HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
  • HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
  • MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
  • Invizyne Technologies Begins Trading on NASDAQ
  • Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024

Recent Comments

    Archives

    • December 2024
    • November 2024
    • October 2024
    • July 2024
    • May 2024
    • April 2024
    • February 2024
    • January 2024
    • November 2023
    • October 2023
    • June 2023
    • May 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Join Mailing List

    Terms of Use  |  Governance  |  Business Continuity  |  Member FINRA/SIPC  |  FINRA’s BrokerCheck  |  Disclosures
    © 2024 MDB Capital